CLINICAL_TRIALS
research
· 2025-12-09
Clinical Trial Update: To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A [Phase 3]
Summary
A Phase 3 clinical trial evaluating GS1191-0445 Injection for the treatment of Hemophilia A, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gritgen Therapeutics Co., Ltd. | Conditions: Hemophilia A | Phase 3 | Status: RECRUITING